{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:37:25Z","timestamp":1793471845268,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s40257-019-00487-x","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T07:02:35Z","timestamp":1575010955000},"page":"285-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Malignant Melanoma of the Vulva and Vagina: A US Population-Based Study of 1863 Patients"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3184-0980","authenticated-orcid":false,"given":"Christoph","family":"Wohlmuth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Wohlmuth-Wieser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taymaa","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Vicus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian T.","family":"Gien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Laframboise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"key":"487_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.6004\/jnccn.2017.0008","volume":"15","author":"W-J Koh","year":"2017","unstructured":"Koh W-J, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, et al. Vulvar cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2017;15:92\u2013120.","journal-title":"J Natl Compr Cancer Netw"},{"key":"487_CR2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.6004\/jnccn.2016.0101","volume":"14","author":"DG Coit","year":"2016","unstructured":"Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE, et al. NCCN guidelines insights: melanoma, version 3.2016. J Natl Compr Cancer Netw. 2016;14:945\u201358.","journal-title":"J Natl Compr Cancer Netw"},{"key":"487_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1200\/JCO.2017.75.7724","volume":"36","author":"SL Wong","year":"2018","unstructured":"Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, et al. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology clinical practice guideline update. J Clin Oncol. 2018;36:399\u2013413.","journal-title":"J Clin Oncol"},{"key":"487_CR4","doi-asserted-by":"publisher","first-page":"v126","DOI":"10.1093\/annonc\/mdv297","volume":"26","author":"R Dummer","year":"2015","unstructured":"Dummer R, Hauschild A, Lindenblatt N, Pentheroudakis G, Keilholz U. Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26:v126\u201332.","journal-title":"Ann Oncol"},{"key":"487_CR5","unstructured":"AWMF. S3-Leitlinie zur Diagnostik, Therapie und Nachsorge des Melanoms, V 3.1. AWMF; 2018. . https:\/\/www.awmf.org. Accessed 23 Oct 2019."},{"key":"487_CR6","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/cncr.30473","volume":"123","author":"JY Hou","year":"2017","unstructured":"Hou JY, Baptiste C, Hombalegowda RB, Tergas AI, Feldman R, Jones NL, et al. Vulvar and vaginal melanoma: a unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma. Cancer. 2017;123:1333\u201344.","journal-title":"Cancer"},{"key":"487_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/CMR.0000000000000480","volume":"28","author":"O Saglam","year":"2018","unstructured":"Saglam O, Messina J, Naqvi SMH, Teer JK, Lee J, Zhang Y, et al. Female genitourinary tract melanoma: mutation analysis with clinicopathologic correlation; a single-institution experience. Melanoma Res. 2018;28:586\u201391.","journal-title":"Melanoma Res"},{"key":"487_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/LGT.0000000000000142","volume":"19","author":"M Rouzbahman","year":"2015","unstructured":"Rouzbahman M, Kamel-Reid S, Al Habeeb A, Butler M, Dodge J, Laframboise S, et al. Malignant melanoma of vulva and vagina. J Low Genit Tract Dis. 2015;19:350\u20133.","journal-title":"J Low Genit Tract Dis."},{"key":"487_CR9","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1002\/1097-0142(19940515)73:10<2626::AID-CNCR2820731026>3.0.CO;2-U","volume":"73","author":"GL Phillips","year":"1994","unstructured":"Phillips GL, Bundy BN, Okagaki T, Kucera PR, Stehman FB. Malignant melanoma of the vulva treated by radical hemivulvectomy: a prospective study of the gynecologic oncology group. Cancer. 1994;73:2626\u201332.","journal-title":"Cancer"},{"key":"487_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/0090-8258(92)90300-8","volume":"45","author":"EL Trimble","year":"1992","unstructured":"Trimble EL, Lewis JL, Williams LL, Curtin JP, Chapman D, Woodruff JM, et al. Management of vulvar melanoma. Gynecol Oncol. 1992;45:254\u20138.","journal-title":"Gynecol Oncol"},{"key":"487_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1046\/j.1525-1438.2001.01043.x","volume":"11","author":"CF Verschraegen","year":"2001","unstructured":"Verschraegen CF, Benjapibal M, Supakarapongkul W, Levy LB, Ross M, Atkinson EN, et al. Vulvar melanoma at the M. D. Anderson Cancer Center: 25\u00a0years later. Int J Gynecol Cancer. 2001;11:359\u201364.","journal-title":"Int J Gynecol Cancer"},{"key":"487_CR12","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2353::AID-CNCR13>3.0.CO;2-#","volume":"78","author":"G R\u00e4ber","year":"1996","unstructured":"R\u00e4ber G, Mempel V, Jackisch C, Hundeiker M, Heinecke A, K\u00fcrzl R, et al. Malignant melanoma of the vulva: report of 89 patients. Cancer. 1996;78:2353\u20138.","journal-title":"Cancer"},{"key":"487_CR13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ygyno.2016.04.021","volume":"142","author":"N Pleunis","year":"2016","unstructured":"Pleunis N, Schuurman MS, Van Rossum MM, Bulten J, Massuger LF, De Hullu JA, et al. Rare vulvar malignancies; incidence, treatment and survival in the Netherlands. Gynecol Oncol. 2016;142:440\u20135.","journal-title":"Gynecol Oncol"},{"key":"487_CR14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jogc.2018.07.011","volume":"41","author":"SE Sinasac","year":"2019","unstructured":"Sinasac SE, Petrella TM, Rouzbahman M, Sade S, Ghazarian D, Vicus D. Melanoma of the vulva and vagina: surgical management and outcomes based on a clinicopathologic review of 68 cases. J Obstet Gynaecol Can. 2019;41:762\u201371.","journal-title":"J Obstet Gynaecol Can"},{"key":"487_CR15","unstructured":"Gershenwald JE, Hess KR, Thompson JF, Long GV, Ross MI, Lazar AJ, et al. Melanoma of the skin. In: AJCC cancer staging manual, 8th ed. American Joint Committee on Cancer; 2017. p. 563\u201388."},{"key":"487_CR16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi FS, O\u2019Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711\u201323.","journal-title":"N Engl J Med"},{"key":"487_CR17","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","volume":"377","author":"JD Wolchok","year":"2017","unstructured":"Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, Grob J-J, Cowey CL, et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 2017;377:1345\u201356.","journal-title":"N Engl J Med"},{"key":"487_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1056\/NEJMoa1412690","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Grange F, Mortier L, Karaszewska B, Rutkowski P, Mackiewicz A, et al. Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med. 2015;372:30\u20139.","journal-title":"N Engl J Med"},{"key":"487_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0140-6736(15)60898-4","volume":"386","author":"GV Long","year":"2015","unstructured":"Long GV, Stroyakovskiy D, Gogas H, Levchenko E, De Braud F, Larkin J, et al. Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial. Lancet. 2015;386:444\u201351.","journal-title":"Lancet"},{"key":"487_CR20","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, et al. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med. 2015;372:2521\u201332.","journal-title":"N Engl J Med"},{"key":"487_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1200\/JCO.2016.67.9258","volume":"35","author":"SP D\u2019Angelo","year":"2017","unstructured":"D\u2019Angelo SP, Larkin J, Sosman JA, Lebb\u00e9 C, Brady B, Neyns B, et al. Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis. J Clin Oncol. 2017;35:226\u201335.","journal-title":"J Clin Oncol"},{"key":"487_CR22","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41416-018-0207-6","volume":"119","author":"O Hamid","year":"2018","unstructured":"Hamid O, Robert C, Ribas A, Hodi FS, Walpole E, Daud A, et al. Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006. Br J Cancer. 2018;119:670\u20134.","journal-title":"Br J Cancer"},{"key":"487_CR23","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: incidence\u2014SEER 18 Regs research data\u2009+\u2009Hurricane Katrina impacted Louisiana cases, Nov 2018 sub (1975\u20132016 varying)\u2014linked to county attributes\u2014total. https:\/\/seer.cancer.gov. Accessed 28 Jul 2019."},{"key":"487_CR24","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1158\/1078-0432.CCR-16-2126","volume":"23","author":"P Nagarajan","year":"2017","unstructured":"Nagarajan P, Curry JL, Ning J, Piao J, Torres-Cabala CA, Aung PP, et al. Tumor thickness and mitotic rate robustly predict melanoma-specific survival in patients with primary vulvar melanoma: a retrospective review of 100 cases. Clin Cancer Res. 2017;23:2093\u2013104.","journal-title":"Clin Cancer Res"},{"key":"487_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/jnci\/djy086","volume":"111","author":"M Lattanzi","year":"2019","unstructured":"Lattanzi M, Lee Y, Simpson D, Moran U, Darvishian F, Kim RH, et al. Primary melanoma histologic subtype: impact on survival and response to therapy. J Natl Cancer Inst. 2019;111:186\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"487_CR26","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/annonc\/mdm087","volume":"18","author":"E de Vries","year":"2007","unstructured":"de Vries E, Houterman S, Janssen-Heijnen MLG, Nijsten T, van de Schans SAM, Eggermont AMM, et al. Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands. Ann Oncol. 2007;18:1110\u20136.","journal-title":"Ann Oncol"},{"key":"487_CR27","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","volume":"375","author":"AMM Eggermont","year":"2016","unstructured":"Eggermont AMM, Chiarion-Sileni V, Grob J-J, Dummer R, Wolchok JD, Schmidt H, et al. Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy. N Engl J Med. 2016;375:1845\u201355.","journal-title":"N Engl J Med"},{"key":"487_CR28","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","volume":"377","author":"J Weber","year":"2017","unstructured":"Weber J, Mandala M, Del Vecchio M, Gogas HJ, Arance AM, Cowey CL, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med. 2017;377:1824\u201335.","journal-title":"N Engl J Med"},{"key":"487_CR29","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","volume":"378","author":"AMM Eggermont","year":"2018","unstructured":"Eggermont AMM, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, et al. Adjuvant pembrolizumab versus placebo in resected stage III melanoma. N Engl J Med. 2018;378:1789\u2013801.","journal-title":"N Engl J Med"},{"key":"487_CR30","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376:2211\u201322.","journal-title":"N Engl J Med"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-019-00487-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-019-00487-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-019-00487-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T19:07:56Z","timestamp":1606504076000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-019-00487-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["487"],"URL":"https:\/\/doi.org\/10.1007\/s40257-019-00487-x","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]},"assertion":[{"value":"29 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No external funding was used in the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Christoph Wohlmuth, Iris Wohlmuth-Wieser, Taymaa May, Danielle Vicus, Lilian T. Gien, and St\u00e9phane Laframboise have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}